logo
Liquidity driving market; overweight on hotels, real estate & REIT: Venkatesh Balasubramaniam

Liquidity driving market; overweight on hotels, real estate & REIT: Venkatesh Balasubramaniam

Economic Times12 hours ago

Tired of too many ads?
Remove Ads
, MD & Head of Research,, says despite real estate stocks trading above NAV, he favours DLF and REITs, attracted by potential interest rate declines boosting REIT yields . He is also overweight on hotels , citing limited investment and strong demand creating a favorable structural play. Leela Hotels and Chalet Hotels are specifically mentioned as preferred stocks. JM Financial is overweight on hotels, real estate, and REITs – all of which are outside the Nifty.We believe this is basically running on liquidity. Domestic flows have been very strong. The monthly SIP numbers are still very strong at almost 267 billion per month. Even though mutual funds have roughly 5% of their holdings in cash, every month when you get these holdings, when you get these flows, you need to deploy it, so that is one thing. Secondly, since March onwards, FII inflows have actually turned positive. So, March, April, May, and in June so far, FII flows have been positive. So, definitely this is running on flows.Fundamentals are not that weak. Fundamentals are okay. The economic outlook is also quite good. But as valuations are not attractive – be it in largecaps, midcaps, or smallcaps – all are trading at one standard deviation or more above the mean. So, it is very tough to make a positive call based on valuations. Fundamentals are okay, outlook is okay, but at this point in time, whatever runup we are seeing is more because of flows.We are benchmarked to the Nifty and in the Nifty 50, there is no real estate stock. So, if we like any real estate stock, automatically we go overweight on real estate. Broadly, the real estate sector is not cheap. Most of the stocks are trading almost 15% to 20% above their NAV. Historically, trading bands are 15-20% below NAV. We are very selective when we come to stocks. We like DLF because it is trading on par. We also like the REIT names primarily because as interest rates come down, a lot of these REITs become very attractive. They are all trading at roughly around 7% yield and 10% growth. It is more of an interest rate kind of a play when it comes to REITs.Real estate, we like from an interest rate perspective, but it is not that we are positive on all real estate stocks, because some of them are expensive and we are aware that over the last couple of quarters and the next couple of quarters also are going to be a little bit on the softer side.Coming to hotels, it has got nothing to do with Maha Kumbh. Over the last four to five years, hardly any investments have been done in the hotel sector. So, there is a lot of demand, but the supply is not adequate. We believe this is likely to continue over the next year, year-and-a-half or so. From that perspective, we like hotels as a structural play. Some of the stocks we like are recently listed Leela Hotels. We also like Chalet Hotels here. These are two names which we like. So, we are overweight on hotels, real estate, and REITs. Incidentally, none of them are a part of the Nifty.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare
Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare

Economic Times

time2 hours ago

  • Economic Times

Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare

Fortis Healthcare is poised for robust growth, driven by hospital expansion and a turnaround in its diagnostics business. With plans to add 900+ beds and expectations of 14–15% revenue growth in FY26, analysts remain bullish. Brownfield expansions and improving ARPOB are likely to support margin improvement and top-line growth. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Shares of Fortis Healthcare has risen 11% in three months, outperforming the 2.3% gain in the ET Pharma index. The company registered decent earnings in the March 2025 quarter. It plans to add around 900 beds next year. It expects revenue to grow by 14-15% for FY26 along with 150-200 basis point margin expansion, driven by better occupancy. Analysts have maintained an 'Outperform' rating on the company had 4,750 operational beds, including operations and management (O&M) contracts, as of March 2025. It aims for 20% additional capacity, which is 900-1,000 beds by FY26 and another 1,000 by February 2025, Fortis Healthcare's wholly owned subsidiary, Fortis Hospotel , acquired Shrimann Superspecialty Hospital in Jalandhar, which had 220 beds. The company has received an occupancy certificate (OC) for 150 beds in Noida, which will be operational soon. A 200-bed facility will be opened in Manesar, a 220-bed expansion in Fortis Memorial Research Institute and another 140-bed facility in BG Road, for which OC is the March 2025 quarter, revenue grew 12.4% year-on-year to Rs2,007.2 crore, driven by strong momentum in the hospital business, which constituted 85% of the revenue. The hospital segment recorded 14% YoY revenue growth, supported by a 5.5% increase in occupancy rates and an 8.4% rise in the average revenue per occupied bed (ARPOB) while the performance of the diagnostics division remained subdued amid a rebranding EBITDA margin improved by 40 basis points year-on-year to 21.7%. However, the net profit fell by 26.1% to Rs 188 crore due to a one-off impairment charge of Rs 53.6 diagnostics segment, which was rebranded to Agilus from SRL two years ago, remains a work in progress with just 3% year-on-year increase in revenue in the March quarter. Fortis expects a stronger performance from FY26, given that the exercise of brand transitioning and costs related to it are now behind. It expects double-digit revenue growth for the division with a 23-25% margin in a couple of years. BNP Paribas has maintained 'Outperform' on Fortis, raising the hospital segment's EBITDA estimate by 3% for FY26-28. JM Financial expects Fortis to show the strongest ARPOB growth , driven by brownfield expansions and increased metro presence. 'With the on-going efforts to improve the profitability of underperforming units, combined with significant brownfield expansion, the company is poised to achieve over 15% topline growth over the next three years, along with 200-300 bps margin (improvement)', JM Financial said in a report.

Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare
Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare

Time of India

time2 hours ago

  • Time of India

Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare

Shares of Fortis Healthcare has risen 11% in three months, outperforming the 2.3% gain in the ET Pharma index. The company registered decent earnings in the March 2025 quarter. It plans to add around 900 beds next year. It expects revenue to grow by 14-15% for FY26 along with 150-200 basis point margin expansion, driven by better occupancy. Analysts have maintained an 'Outperform' rating on the stock. The company had 4,750 operational beds, including operations and management (O&M) contracts, as of March 2025. It aims for 20% additional capacity, which is 900-1,000 beds by FY26 and another 1,000 by FY27. In February 2025, Fortis Healthcare's wholly owned subsidiary, Fortis Hospotel , acquired Shrimann Superspecialty Hospital in Jalandhar, which had 220 beds. The company has received an occupancy certificate (OC) for 150 beds in Noida, which will be operational soon. A 200-bed facility will be opened in Manesar, a 220-bed expansion in Fortis Memorial Research Institute and another 140-bed facility in BG Road, for which OC is expected. In the March 2025 quarter, revenue grew 12.4% year-on-year to Rs2,007.2 crore, driven by strong momentum in the hospital business, which constituted 85% of the revenue. The hospital segment recorded 14% YoY revenue growth, supported by a 5.5% increase in occupancy rates and an 8.4% rise in the average revenue per occupied bed (ARPOB) while the performance of the diagnostics division remained subdued amid a rebranding exercise. Consolidated EBITDA margin improved by 40 basis points year-on-year to 21.7%. However, the net profit fell by 26.1% to Rs 188 crore due to a one-off impairment charge of Rs 53.6 crore. Live Events The diagnostics segment, which was rebranded to Agilus from SRL two years ago, remains a work in progress with just 3% year-on-year increase in revenue in the March quarter. Fortis expects a stronger performance from FY26, given that the exercise of brand transitioning and costs related to it are now behind. It expects double-digit revenue growth for the division with a 23-25% margin in a couple of years. BNP Paribas has maintained 'Outperform' on Fortis, raising the hospital segment's EBITDA estimate by 3% for FY26-28. JM Financial expects Fortis to show the strongest ARPOB growth , driven by brownfield expansions and increased metro presence. 'With the on-going efforts to improve the profitability of underperforming units, combined with significant brownfield expansion, the company is poised to achieve over 15% topline growth over the next three years, along with 200-300 bps margin (improvement)', JM Financial said in a report.

Sebi Approves NPCI's e-KYC Setu System for Easy Digital KYC by Registered Intermediaries
Sebi Approves NPCI's e-KYC Setu System for Easy Digital KYC by Registered Intermediaries

Economic Times

time2 hours ago

  • Economic Times

Sebi Approves NPCI's e-KYC Setu System for Easy Digital KYC by Registered Intermediaries

(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store